
(AGENPARL) – BRISTOL (UK) lun 22 maggio 2023 Clinical trials of an easy-to-use home therapeutic treatment for SARS-CoV-2 (coronaviruses) are underway following a £1.5 million investment into University of Bristol spin-out, Halo Therapeutics.
Fonte/Source: https://www.bristol.ac.uk/news/2023/may/halo-therapeutics-invest.html